A recent analysis has unveiled a concerning trend: a significant rise in cancer patients opting to use ivermectin instead of traditional chemotherapy. The report, published in the JAMA Network, highlights a doubling of ivermectin prescriptions for cancer treatment from January to July 2025, with specific demographic patterns emerging. Notably, white southern males are leading this shift, raising questions about the influence of misinformation and celebrity endorsements in medical decision-making.
The Data Behind the Trend
The JAMA Network study indicates that the use of ivermectin among cancer patients has increased by 2.5 times compared to the same period in 2024. This spike correlates with a notable endorsement from actor Mel Gibson during an episode of the Joe Rogan Experience, which aired on January 9, 2025. In this episode, Gibson claimed that three of his friends had successfully battled cancer using ivermectin and benzimidazole, a compound often found in agricultural products.
The researchers behind the study—Drs Michelle S. Rockwell, Katherine L. Kahn, and A. Mark Fendrick—expressed deep concern over the findings. They noted, “The elevated prescribing observed among patients with cancer is particularly concerning; individuals facing life-threatening illness may delay or forgo conventional treatments in favour of unproven therapies, potentially allowing their disease to progress.” With over 60 million views across various platforms, the episode significantly amplified the reach of this health misinformation.
Celebrity Influence and Health Misinformation
The role of celebrity endorsements in shaping public perception is not new, but its impact on health decisions is particularly alarming. The study suggests that the demographic characteristics of those prescribed ivermectin align closely with the audience of the platforms promoting these treatments. This correlation underscores the selective amplification of misinformation, particularly in contexts where vulnerable populations are looking for hope in the face of severe illness.
Dr Richard Simcock, chief medical officer at MacMillan Cancer Support, commented on the widespread belief in ivermectin’s purported benefits. He expressed astonishment at the number of individuals seeking the drug based solely on social media claims, stating, “There is currently zero real-world clinical evidence that it might be helpful in the treatment of cancer.” While some laboratory studies have suggested potential effects of ivermectin in conjunction with established cancer therapies, these findings cannot be directly translated to clinical practice.
The Risks of Misguided Choices
Despite the allure of alternative treatments, the reality remains stark. Ivermectin is primarily an anti-parasitic medication, and its efficacy against cancer has not been substantiated through rigorous clinical trials. Moreover, the use of ivermectin can lead to adverse effects, including increased nausea and discomfort for those already battling cancer. As Dr Simcock pointed out, the promising lab results observed in conjunction with other treatments do not support the use of ivermectin as a standalone therapy.
The ongoing promotion of ivermectin by various public figures, including RFK Jr., who previously advocated for its use as an alternative to COVID-19 vaccines, further complicates the issue. The lack of regulatory approval from the Food and Drug Administration for any use beyond treating parasites raises critical questions about the safety and validity of these claims.
Why it Matters
The surge in ivermectin prescriptions among cancer patients is not merely a statistical anomaly; it reflects a broader crisis of public health misinformation. As individuals facing life-threatening diseases turn to unproven therapies, the potential for deteriorating health outcomes increases dramatically. This trend underscores the urgent need for accurate information dissemination and the critical role of healthcare professionals in guiding patients towards evidence-based treatments. With the stakes this high, it is imperative that we confront the sources of misinformation and reinforce the importance of rigorous scientific standards in medical care.
